SIRNA THERAPEUTICS INC 4
4 · SIRNA THERAPEUTICS INC · Filed Jul 14, 2005
Insider Transaction Report
Form 4
VEF MANAGEMENT III LLC
10% Owner
Transactions
- Other
Warrant (right to buy)
2005-06-30−23,752→ 0 total(indirect: By Fund)Exercise: $3.85From: 2004-12-30Exp: 2009-12-30→ Common Stock (23,752 underlying) - Purchase
Warrant (right to buy)
2005-06-30+23,752→ 23,752 total(indirect: By Fund)Exercise: $2.00From: 2004-12-30Exp: 2009-12-30→ Common Stock (23,752 underlying)
Footnotes (2)
- [F1]Represents the adjustment in the exercise price of the warrant which was originally issued on December 30, 2004 (the "Warrant"). Pursuant to the terms of the Warrant, the exercise price was automatically adjusted downward from $3.85 to $2.00 per share (the average closing selling price of the common stock over the 15-day period ending on June 30, 2005). No additional consideration was provided by the Reporting Person in consideration for this adjustment.
- [F2]Securities held of record by Venrock Entrepreneurs Fund III, L.P., a limited partnership of which VEF Management III LLC is the General Partner. VEF Management III LLC disclaims beneficial ownership of these securities except to the extent of its pro-rata interest.